First test of new alcohol curbing drug begins in humans
NCT ID NCT06633562
Summary
This is a very early, first-in-human study to check if a new drug called Nezavist is safe and how it moves through the body. It involves 32 healthy adults who will receive either a single dose of the drug or a placebo. The main goal is to find the highest safe dose and understand how the body processes the drug, laying the groundwork for future studies in people with alcohol use disorder.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Altman Clinical and Translational Research Institute
La Jolla, California, 92037, United States
Conditions
Explore the condition pages connected to this study.